CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Grant or award Chief Medical Officer acquired 27,500 shares (grant or award)
- 4 Grant or award President acquired 35,000 shares (grant or award)
- 4 Grant or award SVP, Finance and Treasurer acquired 10,000 shares (grant or award)
- 4 Grant or award CEO acquired 77,500 shares (grant or award)
- 4/A Option exercise CEO acquired 30,000 shares (option exercise)
- 4 Planned sale SVP, Finance and Treasurer sold 6,287 shares at $35.00 ($220,045)
- 4 Planned sale Chief Legal Officer sold 10,000 shares at $34.00 ($340,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale CEO sold 30,000 shares at an average $26.75 ($802,484)
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Legal Officer sold 1,241 shares at $24.68 ($30,628)
- 4 Planned sale SVP, Finance and Treasurer sold 1,117 shares at $24.68 ($27,568)
- 4 Grant or award Chief Financial Officer acquired 80,000 shares (grant or award)
- 4 Option exercise President acquired 53,500 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President sold 51,110 shares at $26.36 ($1,347,050)
Page 4 of 12 · 238 filings